Looks like UNS has a future, page-7

from the preso slides, page 18
"2017 commence supply for clinical trials" . .
Customer programs complete device design verification
Production and supply of clinical batches for customers for human clinical trials

"2018 commence commercial scale-up" . .
Production and supply of commercial equivalent devices for validation and customer pre-launch activities

"2019 commence commercial sales" . . .
Commercial sales for anticipated patient use commence to meet customer program schedules

"2020 onwards - continued commercial growth" . . ( . . and . . . . boom . . )
. . even if bottom drawer for a while longer, at last we have more realistic timelines - so still feel worth hanging in there ! !